Intel heads into October with its stock pulling back from last week's highs, shorts holding steady, and the Street locked in a debate that Q3 results on October 22 will need to resolve.
The price move is the clearest shift this week. Intel closed Tuesday at $115.93, down 6.4% over five days after briefly trading above $123 in the prior session. That pullback follows an extraordinary run: the stock is still up nearly 30% over the past month and has more than tripled year-to-date. The week's decline is the most sustained consolidation since the September 21 short-squeeze breakout, and it arrives just three weeks before the Q3 print. Most correlated peers moved in the opposite direction. MXL gained 6%, FORM added 8%, and LRCX rose 4% on the week, making Intel's pullback clearly stock-specific rather than a sector read.
Positioning has not changed materially, and that is worth noting. Short interest edged up a fraction over the week to 3.3% of free float, essentially flat after several weeks of quiet rebuilding from the post-squeeze lows. The month-on-month figure is up 33%, driven by accumulation that began in early September. Borrow conditions remain no obstacle to new shorts: availability is effectively unlimited, with over five billion shares in the lending pool barely touched. Cost to borrow has drifted higher this week, up 17%, but at 0.40% it remains near the floor of the past year. There is no friction in the lending market. Options tell a more interesting story. The put/call ratio has dropped to 0.84, roughly 1.5 standard deviations below its 20-day average of 0.87. That is the most call-heavy positioning seen in months, despite the stock pulling back. Options traders appear to be leaning into the earnings setup rather than hedging against it.
The Street remains structurally divided, and recent analyst activity has done little to narrow the gap. TD Cowen reiterated Hold with a $115 target last week, essentially marking the stock fairly valued at current levels. Tigress Financial raised its target to $145, while Piper Sandler initiated at Neutral with a $110 target. Northland upgraded to Outperform in early September. Mizuho, on the other hand, cut its target to $92 in early September, the most bearish call in the recent batch. Bank of America, which holds a Buy, trimmed its target to $145 from $160 in August. The consensus price target sits near $116, almost exactly where the stock trades, suggesting the Street in aggregate sees no near-term upside. The bull case centres on Q2's 25% revenue growth, Data Center and AI revenue up 59%, and a foundry business beginning to scale. The bear case questions whether share loss in core CPU markets can be arrested before 2027 and whether the foundry customer pipeline is as firm as bulls assume. Valuation is not cheap: the trailing PE has expanded to roughly 60x over the past month, rising alongside the stock, and EV/EBITDA is near 19x.
The one insider data point worth carrying forward is CEO Lip-Bu Tan's open-market purchase of 105,263 shares at $95 on August 11, a $10 million commitment made without a 10b5-1 plan. That trade is now sitting on a 22% gain and remains the most significant discretionary insider signal in the recent record. Net insider activity over the past 90 days is positive at roughly $7.5 million, though most of the other recent transactions are option exercises and tax-withholding sales rather than open-market conviction buys.
The October 22 earnings report is now the single organising event for everything in this note: whether the call-heavy options positioning proves prescient, whether SI rebuilds further into the print or pares back, and whether the Street's bifurcated targets start converging on one side of the bull-bear debate.
See the live data behind this article on ORTEX.
Open INTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
